Jones Financial Companies
SANA icon

Jones Financial Companies’s Sana Biotechnology SANA Stock Holding History

Jones Financial Companies’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.4K Sell
9,168
-10
-0.1% -$39 ﹤0.01% 3201
2025
Q4 		$37.4K Buy
9,178
+1,655
+22% +$7.41K ﹤0.01% 2661
2025
Q3 		$25.1K Buy
7,523
+1,355
+22% +$4.9K ﹤0.01% 2677
2025
Q2 		$17.3K Hold
6,168
– – ﹤0.01% 2664
2025
Q1 		$10.5K Hold
6,168
– – ﹤0.01% 2676
2024
Q4 		$10.1K Buy
+6,168
New +$18.4K ﹤0.01% 2525

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Jones Financial Companies's SANA Position: Q1 2026 in Review

Jones Financial Companies reduced its Sana Biotechnology (SANA) stake by 0.11% in Q1 2026, selling an estimated $39 and leaving 9,168 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

Jones Financial Companies first reported a position in SANA in Q4 2024 and has held it in 6 quarters since. The position peaked at $37.4K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Jones Financial Companies held 9,168 shares of Sana Biotechnology worth $25.4K as of Q1 2026.
  • Jones Financial Companies sold 10 Sana Biotechnology shares in Q1 2026, an estimated $39.
  • Sana Biotechnology made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3201 holding.
  • Jones Financial Companies first reported a position in Sana Biotechnology in Q4 2024 and has held it in 6 quarters since.
  • Jones Financial Companies's Sana Biotechnology position peaked at $37.4K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.